CareDx
27
1
6
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.5%
5 terminated/withdrawn out of 27 trials
64.3%
-22.2% vs industry average
11%
3 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
Surveillance HeartCare® Outcomes Registry
Role: lead
AlloSure Lung Assessment and Metagenomics Outcomes Study
Role: lead
Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test
Role: lead
Molecular Assessment and Profiling of Liver Transplant Recipients
Role: lead
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
Role: collaborator
Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Role: collaborator
Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction
Role: collaborator
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
Role: collaborator
Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
Role: lead
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
Role: lead
AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
Role: collaborator
Allosure in Simultaneous Pancreas Kidney Transplant
Role: collaborator
Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation
Role: collaborator
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Role: collaborator
Immune Monitoring to Facilitate Belatacept Monotherapy
Role: collaborator
Transition of Renal Patients Using AlloSure Into Community Kidney Care
Role: lead
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Role: lead
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry
Role: lead
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
Role: lead
Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients
Role: collaborator